Novobiocin Sodium is an aminocoumarin antibiotic utilized in the treatment of infections caused by susceptible gram-positive bacteria, such as Staphylococcus aureus, through the inhibition of bacterial… Read more
Novobiocin Sodium is an aminocoumarin antibiotic utilized in the treatment of infections caused by susceptible gram-positive bacteria, such as Staphylococcus aureus, through the inhibition of bacterial DNA gyrase and topoisomerase IV. Laboratories rely on high-quality reference standards of Novobiocin Sodium to support rigorous quality control and analytical testing protocols. This category encompasses the parent drug API along with its related pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for accurate impurity profiling and method validation, enabling researchers to maintain compliance with regulatory standards. By providing precise, reliable reference materials, these compounds facilitate the development and verification of sensitive analytical methods required for pharmaceutical characterization and stability studies throughout the drug development lifecycle.